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as “adverse selection.” One way to prevent
adverse selection is to promote the forma-
tion of groups, or alliances, for purchasing
insurance that will spread the associated risk
and make premiums more affordable.
Adverse selection has garnered exten-
sive political attention. It served as the driver
behind the Clinton proposal to create “re-
gional health alliances,” and it prompted the
individual mandate in the 2007 Massachu-
setts health care plan shepherded into law by
then Gov. Mitt Romney (who as a Republi-
can presidential candidate now disavows the
mandate). Newt Gingrich’s “Contract with
America” in 1994 helped shift the focus of
health care reform from universal coverage
to cost containment in an effort to create a
balanced budget. Throughout the book, Dr.
Starr  explores  numerous  political  ap-
proaches to adverse selection and examines
the respective effectiveness and validity of
the various approaches.   
Material  in  the  book  is  organized
chronologically,  beginning  with  the  first
mention of “social insurance” and “protec-
tion against the costs of sickness” in the
1912 presidential election by the Progressive
Party. The text touches on relevant histori-
cal predecessors of the PPACA such as a
failed 1943 bill that proposed comprehen-
sive health insurance and the emergence of
employer-based health insurance after World
War II. In 1974, Richard Nixon proposed
comprehensive health insurance that relied
on an employer mandate, but the Watergate
scandal ended the effort. Dr. Star, who was
an advisor to Hillary Clinton’s Health Pol-
icy Task Force, then proceeds to devote al-
most a quarter of the book to the Clinton
administration and its impact on health care
policy. The  author  is  sympathetic  to  the
Clintons but critical of the way they intro-
duced their policy and of the media, and the
book is valuable for its insider’s analysis of
the political factors that led to the failure of
the Clinton health plan. The book ultimately
concludes with chapters on the Massachu-
setts plan, the presidential election of 2008,
and the success of the Obama administration
in effecting passage of PPACA in 2010. Al-
though occasionally dense, Remedy and Re-
action is generally quite readable for the
non-expert. It would be of greatest interest,
though, to historians and health care policy
analysts.  If,  however,  the  U.S.  Supreme
Court finds the individual mandate to be un-
constitutional, then politicians and lobbyists
on both sides of the debate will be scouring
the book for insights and strategies for the
next battle over comprehensive health cov-
erage.
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Fundamentals of Medical Physiology is
a concise textbook of medical physiology
written for first- and second-year medical
students or anyone interested in learning the
core principles of physiology through an in-
troduction to clinical cases in the context of
each organ system. The book is divided into
10 sections, each prefaced with a general
outline of topics covered, a brief overview
of an organ system, and presentation of a rel-
evant clinical case followed by open-ended
questions to think about while reading the
section. While the organization of chapter
topics is conventional, the book’s focus on
highlighting recurring themes underlying
physiological mechanisms (e.g., homeosta-
sis,  energy,  balance  of  forces,  reservoir,
flow, elasticity, and cell-cell communica-
tion) is novel and provides the reader with
additional, alternative ways in which to as-
similate  and  integrate  information.
Schematic  diagrams,  illustrations,  tables,
and figures are amply provided and are use-
ful in understanding and reviewing key in-
formation. Unfortunately, the first section,
“Foundations of Physiology,” which covers
basic cell biology and the concept of control
systems contributing to homeostasis, is not
as detailed as the other sections and thus is
best taken as a brief 24-page refresher. As a
side note, minor errata are also present in the
text, most of which are identifiable in con-Book reviews 161
text. For example, microfilaments are incor-
rectly introduced as being “~35 nm in diam-
eter,” but the same chapter subsection also
provides the correct relative diameters of
microtubules  and  intermediate  filaments.
Perhaps subsequent editions of the textbook
will address these issues.
The strength of the textbook lies in its
ability to promote active learning by apply-
ing acquired physiological knowledge to
clinical cases. The initial case and open-
ended questions of each section, as well as
case-based  “Applying  What You  Know”
questions at the end of each chapter, are en-
gaging even for the non-medical student and
provide a broad conceptual framework that
helps the reader fit pieces of information to-
gether. Importantly, answers to all questions
and a concise case analysis from both clini-
cal and physiological perspectives are given
at the end of each section. Furthermore, an
access code is provided for a supplementary
interactive  online  study  aid,  Wink-
ingSkull.com PLUS, which includes two ad-
ditional clinical cases on the cardiovascular
and  respiratory  systems  and  814  images
from the Atlas of Anatomy with a timed test
feature. The online program also gives read-
ers the option of displaying anatomy labels
in English or Latin. Taken together, these
qualities make Fundamentals of Medical
Physiology a valuable resource. 
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Small Molecular Therapy for Genetic
Diseases is a collection of articles that com-
memorate the Orphan Drug Act that was
passed in 1983 after sustained effort from pa-
tient advocacy groups. The legislation gave
pharmaceutical  companies  various  incen-
tives, such as tax credits, expedited review,
flexible clinical trial requirements, and ex-
clusive marketing to develop treatments that
would otherwise be unprofitable. A recent
search in the on-line Orphan Drug database
(http://www.accessdata.fda.gov/scripts/opdli
sting/oopd/index.cfm) reveals that 370 drugs
have been approved for 180 diseases, with
approximately  2,000  more  drugs  in  the
pipeline. This turnout makes former Office
of  Orphaned  Drugs  Director  Marlene
Haffner proudly conclude at the end of the
first chapter that the “taxpayer’s dollars have
been well spent.” The majority of the ap-
proved products are biological agents such
as enzymes, antibodies, or hormones. An-
other significant portion of drugs are cyto-
toxic agents for malignancies or autoimmune
diseases. Only 24 agents are small molecule
drugs for genetic diseases, but it is this cate-
gory of drugs that provides the focus for the
rest of the book. Although macromolecular
therapy  may  dominate  the  post-genomic
world, the authors remind us that small mol-
ecules have many distinct advantages, such
as easy delivery, straightforward pharmaco-
kenitics, and minimal immune interactions.
After an introductory section covering
legislative backgrounds, infrastructures, and
pharmacology principles, the book reviews
11 examples of effective small molecule
therapy. They are grouped by the molecules’
modality of action as co-factors of enzy-
matic  activities,  activators  of  alternative
pathways to circumvent metabolic defects,
and metal conjugates. In each chapter, an
overview of the pathogenesis and epidemi-
ology of the condition is followed by clini-
cal trial and case study data of the drug. 
The book targets three types of readers:
clinicians and clinical scientists, patients and
patient advocates, and policy makers. The
sense of hope and encouragement that per-
meates the pages enables the book to moti-
vate physicians and researchers to use and
develop  small  molecule  therapies.  But
someone familiar with biomedical sciences
will likely find the articles rather rudimen-
tary. Although the writing is void of jargon
and explains the clinical data in more palat-
able terms than a Cochran Review, it would
be helpful to know what scientific inquiries